Interim Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
PATIENT REVENUES, net	$ 141,500	$ 97,945
EXPENSES:
Operating	110,667	78,618
Lease and rent expense	13,743	7,252
Professional liability	2,670	2,066
General and administrative	8,973	6,734
Depreciation and amortization	2,487	2,003
Total expenses	138,540	96,673
OPERATING INCOME	2,960	1,272
OTHER INCOME (EXPENSE):
Equity in net income of unconsolidated affiliate	0	33
Gain on sale of investment in unconsolidated affiliate	733	0
Interest expense, net	(1,483)	(1,070)
Debt retirement costs	0	(351)
Total other expense	(750)	(1,388)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	2,210	(116)
BENEFIT (PROVISION) FOR INCOME TAXES	(862)	42
INCOME (LOSS) FROM CONTINUING OPERATIONS	1,348	(74)
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit (expense) of ($9) and $21, respectively	(15)	(37)
NET INCOME (LOSS)	$ 1,333	$ (111)
NET INCOME (LOSS) PER COMMON SHARE:
Per common share – basic, Continuing operations (dollars per share)	$ 0.22	$ (0.01)
Per common share – basic, Discontinued operations (dollars per share)	0.00	(0.01)
Net income (loss) per common share – basic (dollars per share)	0.22	(0.02)
Per common share – diluted
Per common share – diluted, Continuing operations (dollars per share)	0.21	(0.01)
Per common share – diluted, Discontinued operations (dollars per share)	0.00	(0.01)
Net income (loss) per common share – diluted (dollars per share)	0.21	(0.02)
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK (dollars per share)	$ 0.055	$ 0.055
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,233	6,160
Diluted (shares)	6,440	6,160